查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198658

經橈動脈通路市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)

Transradial Access Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，經橈動脈通路設備市場預計將以 7.5% 的複合年增長率註冊。

COVID-19 疫情影響了經橈動脈通路裝置研究市場的增長，由於延遲診斷和多次預約推遲，對心臟治療和診斷程序產生了重大影響。 此外，多項研究表明，心髒病患者特別容易感染 COVID-19，從而減少了去醫院和診斷中心的次數。 例如，NCBI 於 2021 年 5 月發布的一項研究發現，在 COVID-19 流行期間，英國的心臟手術活動急劇下降，大約有 45,000 例手術出現虧損。 此外，2021 年 12 月發表在 Frontiers in Family Medicine and Primary Care 上的一項研究發現，儘管有冠狀動脈疾病 (CAD) 的症狀，但仍有 9.1% 的德國患者擔心感染 COVID-19。他說他從未見過醫生。 然而，該研究還詳細說明，大多數患者在 COVID-19 流行期間接受了充分的 CAD 醫療護理。 由於心臟診斷和治療的可用性不斷提高，預計該市場將在後期受到積極影響。

由於越來越傾向於使用橈動脈通路進行介入治療、生活方式相關疾病引起的心髒病流行以及兒科患者越來越多地使用橈動脈通路裝置，因此經橈動脈通路裝置市場正在擴大。

根據世衛組織 2021 年 6 月更新的數據，全球約有 3350 萬人患有心房顫動 (AFib)，使其成為最常見的嚴重心律失常類型。我來了。 此外，英國心臟基金會於 2021 年 7 月發布的一份報告稱，英國有 760 萬人患有心臟和循環系統疾病。 此外，根據 2022 年 AHA 報告，全球約有 2.441 億人患有 IHD。 到 2020 年，北非、中東、中亞、南亞和東歐將成為全球 IHD 患病率最高的地區。 隨著全球人口老齡化，患有心律失常的患者數量預計會增加。 預計這將增加經橈動脈通路的採用，並推動所研究市場的增長。

根據美國心臟協會 (AHA) 於 2021 年 8 月發布的一項科學研究，外周下肢動脈疾病 (PAD) 影響著全球超過 2.3 億人，並具有多種不利的臨床結果（冠狀動脈疾病），它與心髒病風險增加有關和中風，包括截肢等肢體後果。 PAD 發病率的增加將增加對需要經橈動脈入路的介入治療的需求，從而在預測期內增加市場增長。

然而，市場增長的主要製約因素是安裝和維護血管通路裝置的高成本以及缺乏訓練有素的專業人員，這構成了重大挑戰。

經橈動脈通路市場趨勢

導管部分預計在預測期內增長

導管部分預計在預測期內會出現增長。 在所有類型的動脈血管介入治療中，通過左橈動脈的經橈動脈通路 (TRA) 是一種越來越相關的基於導管的替代方法，可替代傳統的經股動脈通路。 心導管插入術是幫助診斷心髒病的常見程序。 在某些情況下，導管插入術還用於打開被球囊血管成形術或支架置入術阻塞的動脈以治療心髒病。

心導管檢查有助於診斷多種心髒病，包括動脈硬化、心肌病、先天性心髒病、心力衰竭和心臟瓣膜病。 由於全球心血管疾病負擔的增加，預計導管部分將出現顯著增長。 根據疾病預防控制中心 2022 年 2 月發布的更新，2020 年美國有 4.6% 的成年人被診斷出患有冠心病。 此外，截至 2021 年 2 月，美國每年約有 150 萬例心髒病發作和中風。 此外，根據 2021 年泛美衛生組織的數據，心血管疾病在美洲造成 4080 萬傷殘調整生命年 (DALYs)。 根據國家慢性病預防與健康促進中心 2022 年 7 月更新的數據，冠心病是最常見的心髒病類型。 此外，美國每年約有 805,000 人心髒病發作。 在這種情況下，公眾對疾病控制和診斷重要性的認識正在提高。

因此，上述因素有望在預測期內推動導管部分的增長。

北美在市場上佔據主導地位，預計在未來幾年內仍將如此

由於 CVD 患病率上升、舉辦的會議和研討會數量增加以及血管通路裝置研究和臨床試驗增加等因素，預計北美市場將以最快的速度增長。.

根據 CDC 於 2020 年 9 月發表的一篇文章，心髒病是美國的頭號死因。 同一消息來源還報導說，每年約有 805,000 名美國人心髒病發作。 由於心髒病導致的死亡人數不斷增加，對心髒病進行適當治療和診斷的需求不斷增加，預計經橈動脈通路裝置將在預測期內顯示增長，因為它們有助於診斷。

根據疾病預防控制中心 2022 年 2 月的更新，2020 年約有 2.1% 的美國兒童健康狀況良好或不佳，2020 年約有 3.3% 的 5 至 11 歲兒童因任何原因缺課 11 天或更多天在過去 12 個月內生病或受傷。 此外，如上述來源所述，美國約有 20.3% 的 6 至 11 歲兒童肥胖，而肥胖是各種疾病的主要危險因素之一。預計負擔會增加，推動兒童的增長正在研究的市場。

預計該地區的經橈動脈通路市場將受益於成熟的醫療保健行業和不斷上漲的醫療保健成本。 例如，根據 2021 年 12 月發布的 NHEA 數據，美國將在 2020 年花費 4400 億美元用於醫療保健。 因此，預計不斷增加的醫療保健成本將刺激經橈動脈通路裝置等新產品的開發，推動預測期內的市場增長。

因此，由於上述因素，北美地區有望在預測期內實現高增長率。

經橈動脈通路市場的競爭對手分析

經橈動脈通路市場競爭激烈且分散，不僅有大型企業，還有一些本地企業。 市場上的主要參與者包括 Becton、Dickinson and Company、Boston Scientific Corporation、Edward Lifesciences Corporation、Medtronic plc 和 Terumo Corporation。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 越來越傾向於使用橈動脈入路進行介入手術
    • 生活方式相關疾病導致心血管疾病患病率上升
    • 在兒科患者中增加橈動脈通路裝置的使用
  • 市場製約因素
    • 血管通路裝置的安裝和維護成本高昂
    • 缺乏訓練有素的專業人員
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品分類
    • 導管
    • 導絲
    • 護套和護套引入器
    • 配飾
  • 通過申請
    • 藥物管理
    • 輸液和營養管理
    • 輸血
    • 診斷和測試
  • 最終用戶
    • 醫院
    • 診所/門診診所
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Ameco Medical
    • Angiodynamics, Inc.
    • Becton, Dickinson and Company
    • Boston Scientific Corporation
    • Edward Lifesciences Corporation
    • Medtronic plc
    • Merit Medical Systems
    • Nipro Medical Corporation
    • Oscor Inc
    • Smiths Medical
    • Teleflex Incorporated
    • Terumo Corporation

第7章 市場機會與今後動向

簡介目錄
Product Code: 60486

The transradial access devices market is expected to register a CAGR of 7.5% over the forecast period.

The COVID-19 pandemic substantially affected the treatment and diagnostic procedures for cardiac practices owing to delayed diagnosis and multiple postponed appointments, thereby impacting the growth of the studied market for transradial access devices. Furthermore, many studies suggested that people with cardiac diseases were particularly vulnerable to COVID-19, which led to a decrease in footfalls in hospitals and diagnostic centers. For instance, according to the research study published by the NCBI in May 2021, during the COVID-19 pandemic, cardiac procedural activity in England decreased dramatically, with a deficit of about 45,000 procedures. Moreover, a study published in Frontiers in Family Medicine and Primary Care in December 2021 stated that in Germany, despite having symptoms of coronary artery disease (CAD), 9.1% of patients did not see a medical practitioner due to a fear of becoming infected with COVID-19. However, the study's findings also detailed that most patients received adequate medical care during the COVID-19 pandemic for CAD. As a result of the growing availability of cardiac diagnosis and treatments, the market is expected to be favorably influenced in the latter phase, as per the analysis.

The transradial access devices market is growing due to the increasing preference for interventional procedures using radial artery access, the growing prevalence of cardiovascular diseases due to lifestyle disorders, and the increasing use of radial access devices in pediatric patients.

According to the WHO data updated in June 2021, nearly 33.5 million people globally are suffering from atrial fibrillation (AFib), which is the most common type of serious arrhythmia. Moreover, the British Heart Foundation's report published in July 2021 reported that 7.6 million people in the United Kingdom live with heart and circulatory diseases. Further, according to the 2022 AHA report, approximately 244.1 million people were living with IHD around the world. North Africa, the Middle East, Central, and South Asia, and Eastern Europe had the highest prevalence rates of IHD in the world in 2020. With the rise in the aging population worldwide, the number of patients suffering from heart rhythm disorders is likely to increase. This will lead to increased adoption of transradial access, which is expected to drive the growth of the studied market. ​

A scientific study published by the AHA in August 2021 stated that lower extremity peripheral artery disease (PAD) affects more than 230 million people worldwide and is linked to an elevated risk of several unfavorable clinical outcomes (including cardiovascular diseases like coronary heart disease and stroke and limb outcomes like amputee status). The increased incidence of PAD ultimately boosts the demand for interventional procedures requiring transradial access, augmenting the market's growth over the forecast period.

However, the major restraining factor for the market's growth is the high costs involved in the placement and maintenance of vascular access devices and the lack of trained professionals, which poses significant challenges.

Transradial Access Market Trends

Catheters Segment is Expected to Witness Growth Over the Forecast Period

The catheter segment is expected to witness growth over the forecast period. Transradial access (TRA) via the left radial artery is an alternative to traditional transfemoral access for catheter-based procedures that are becoming increasingly relevant in all types of arterial vascular interventions. Cardiac catheterization is a common procedure that can help diagnose heart disease. In some cases, catheterization is also used to treat heart disease by opening blocked arteries with balloon angioplasty and stent placement.

Cardiac catheterization helps in the diagnosis of multiple heart diseases, including atherosclerosis, cardiomyopathy, congenital heart disease, heart failure, and heart valve disease. With the growing burden of cardiovascular diseases all over the world, the catheter segment is expected to witness significant growth. As per a February 2022 published update by the CDC, in 2020, the percentage of adults diagnosed with coronary heart disease was 4.6% in the United States. In addition, as of February 2021, approximately 1.5 million heart attacks and strokes occur every year in the United States. Moreover, as per the 2021 PAHO, cardiovascular diseases account for 40.8 million disability-adjusted life years (DALYs) in the Americas. In addition, according to the National Center for Chronic Disease Prevention and Health Promotion data updated in July 2022, coronary heart disease is the most common type of heart disease. Moreover, about 805,000 people in the United States have a heart attack every year. This concerning situation is raising public awareness about disease management and the importance of diagnostics.

Thus, the abovementioned factors are expected to drive catheter segment growth over the forecast period.

North America Dominates the Market and is Expected to Follow the Same Trend for Few More Years

The North American market is likely to grow with the highest growth rate, owing to factors such as the growing prevalence of CVDs, a rising number of conferences and workshops, and an increase in research and clinical trials for vascular access devices.

According to an article published by the CDC in September 2020, heart disease is the leading cause of death in the United States. The same source also reports that every year about 805,000 Americans have a heart attack. As the number of deaths due to heart diseases is increasing, there is a continuous need for the proper treatment and diagnosis of cardiac diseases, since transradial access devices help in the diagnosis and are hence expected to show growth over the forecast period.

According to the CDC updates from February 2022, about 2.1% of children in the United States are in fair or poor health conditions in 2020, and about 3.3% of children aged 5 to 11 in 2020 missed 11 or more days of school in the last 12 months due to some form of illness or injury. Also, as per the above-mentioned source, in the United States, approximately 20.3% of children aged 6 to 11 have obesity, and as obesity is one of the major risk factors for different diseases, the burden of pediatric disease is expected to increase in the country, which would drive growth in the market studied.

The region's transradial access market is expected to benefit from the well-established healthcare industry and rising healthcare expenditure. For instance, according to NHEA data released in December 2021, the United States spent USD 440,000 million on healthcare in 2020. Thus, rising healthcare costs are expected to spur the development of new products such as transradial access devices, which are expected to drive market growth over the forecast period.

Thus, the market is expected to witness a high growth rate over the forecast period due to the factors mentioned above in the North American region.

Transradial Access Market Competitor Analysis

The transradial access market is competitive and fragmented and is inclusive of the big players along with some of the local players in the market. Some of the key players in the market include Becton, Dickinson and Company, Boston Scientific Corporation, Edward Lifesciences Corporation, Medtronic plc, and Terumo Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Preference for Interventional Procedures Using Radial Artery Access
    • 4.2.2 Growing Prevalence of Cardiovascular Diseases Due to Lifestyle Related Diseases
    • 4.2.3 Growing Use of Radial Access Devices in Pediatric Patients
  • 4.3 Market Restraints
    • 4.3.1 High Costs Involved in the Placement and Maintenance of Vascular Access Devices
    • 4.3.2 Lack of Trained Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Catheters
    • 5.1.2 Guidewires
    • 5.1.3 Sheaths and Sheath Introducers
    • 5.1.4 Accessories
  • 5.2 By Application
    • 5.2.1 Drug Administration
    • 5.2.2 Fluid and Nutrition Administration
    • 5.2.3 Blood Transfusion
    • 5.2.4 Diagnostics and Testing
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Clinics and Ambulatory Care Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Ameco Medical
    • 6.1.2 Angiodynamics, Inc.
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Boston Scientific Corporation
    • 6.1.5 Edward Lifesciences Corporation
    • 6.1.6 Medtronic plc
    • 6.1.7 Merit Medical Systems
    • 6.1.8 Nipro Medical Corporation
    • 6.1.9 Oscor Inc
    • 6.1.10 Smiths Medical
    • 6.1.11 Teleflex Incorporated
    • 6.1.12 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS